About Adaptyv Biosystems
Adaptyv Biosystems is a company based in Lausanne (Switzerland) founded in 2021 by Daniel Nakhaee Zadeh Gutierrez, Moustafa Houmani, and Julian Englert.. Adaptyv Biosystems has raised $2.63 million across 4 funding rounds from investors including Axial, Acequia Capital and FAST. Adaptyv Biosystems offers products and services including Cloud Lab and API. Adaptyv Biosystems operates in a competitive market with competitors including Rheonix, Phoremost, 64x Bio, Nanna Therapeutics and reMYND, among others.
- Headquarter Lausanne, Switzerland
- Founders Daniel Nakhaee Zadeh Gutierrez, Moustafa Houmani, Julian Englert
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Adaptyv Biosystems Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.63 M (USD)
in 4 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
Feb 14, 2022
-
Investors
Axial
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Adaptyv Biosystems
Adaptyv Biosystems offers a comprehensive portfolio of products and services, including Cloud Lab and API. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI platform for generating and testing protein designs in biotechnology.
Interface for protein experimentation and data generation tools.
Unlock access to complete
Funding Insights of Adaptyv Biosystems
Adaptyv Biosystems has successfully raised a total of $2.63M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Seed — $2.5M
-
First Round
First Round
(28 Apr 2021)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2022 | Amount | Seed - Adaptyv Biosystems | Valuation | Founderful | |
| Aug, 2021 | Amount | Seed - Adaptyv Biosystems | Valuation | Y Combinator |
|
| Jul, 2021 | Amount | Grant - Adaptyv Biosystems | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Adaptyv Biosystems
Adaptyv Biosystems has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Axial, Acequia Capital and FAST. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early-stage tech companies by Acequia Capital.
|
Founded Year | Domain | Location | |
|
Student-led venture capital fund supporting Swiss student startups.
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Adaptyv Biosystems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Adaptyv Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Adaptyv Biosystems Comparisons
Competitors of Adaptyv Biosystems
Adaptyv Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rheonix, Phoremost, 64x Bio, Nanna Therapeutics and reMYND, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instruments for automated molecular assays are developed using disposable cartridges.
|
|
| domain | founded_year | HQ Location |
Phenotypic screening platform developed to identify drug targets and pathways.
|
|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple diseases are developed.
|
|
| domain | founded_year | HQ Location |
In-vitro directed evolution platform is provided for drug discovery.
|
|
| domain | founded_year | HQ Location |
Developer of a drug pipeline programs for neurodegenerative diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Adaptyv Biosystems
Frequently Asked Questions about Adaptyv Biosystems
When was Adaptyv Biosystems founded?
Adaptyv Biosystems was founded in 2021.
Where is Adaptyv Biosystems located?
Adaptyv Biosystems is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Is Adaptyv Biosystems a funded company?
Adaptyv Biosystems is a funded company, having raised a total of $2.63M across 4 funding rounds to date. The company's 1st funding round was a Grant of $108.28K, raised on Apr 28, 2021.
What does Adaptyv Biosystems do?
Founded in 2021 and based in Lausanne, Switzerland, operations in the biotechnology sector are conducted by Adaptyv Biosystems. Protein design, synthesis, testing, and validation services are provided through an integrated platform. Experimental data is generated to refine protein designs, while protein expression is streamlined and synthesis of custom proteins is enabled. Automated workcells are utilized to profile designs for functional and interactive properties.
Who are the top competitors of Adaptyv Biosystems?
What products or services does Adaptyv Biosystems offer?
Adaptyv Biosystems offers Cloud Lab and API.
Who are Adaptyv Biosystems's investors?
Adaptyv Biosystems has 12 investors. Key investors include Axial, Acequia Capital, FAST, Founders, and Founderful Campus.